Sequential therapy for Helicobacter pylori eradication: Is levofloxacin better?

Gut

Volumn 60, Issue 11, 2011, Pages 1604-

  Zullo, Angelo ^a   De Francesco, V ^b   Vaira, D ^c  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b Riuniti Hospital   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; LEVOFLOXACIN;

ANTIBIOTIC RESISTANCE; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG TREATMENT FAILURE; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION CONTROL; LETTER; NONHUMAN; PRIORITY JOURNAL; SEQUENTIAL THERAPY; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; OFLOXACIN;

EID: 80053562661     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.231233     Document Type: Letter

References (5)

1. Romano M, Cuomo A, Gravina G, et al. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut 2010;59:1465-70.
2. Zullo A, Perna F, Hassan C, et al. Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment Pharmacol Ther 2007;25:1429-34. (Pubitemid 46848887)
3. Molina-Infante J, Perez-Gallardo B, Fernandez-Bermejo M, et al. Clinical trial: clarithromycin vs levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication. Aliment Pharmacol Ther 2010;31:1077-84.
4. Zullo A, Hassan C, D'Ercole C, et al. Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication? Aliment Pharmacol Ther 2010;31:1248-9; author reply 1249-50.
5. Zullo A, Hassan C, Cristofari F, et al. How to manage H. pylori following sequential therapy failure? J Clin Gastroenterol 2010;44:459-60.